ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

NIH Reauthorization Threatened By Fetal Research Issue

October 5, 1990

FDA Approves Avastin Combination For Late-Stage Cervical Cancer

August 29, 2014

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

March 22, 2013

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

Limit On Number Of Surgery Planning Grants Lifted After DCT Board Pressure

March 19, 1982

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992